Table Des Matières; Description; Technical Features; Intended Use - SORIN GROUP D 903 AVANT VAVD Mode D'emploi

GB - ENGLISH
I. CONTENTS
I. Contents
A. Description
B. Technical features
C. Intended use
D. Safety information
E. Set up
F. Priming and recirculation procedure
G. Initiating bypass
H. Operation during bypass
I. Terminating bypass
J. Blood recovery after bypass
K. Use of cardiotomy for post-operative autotransfusion
L. Oxygenator replacement
M. Medical devices for use with the D903 AVANT VAVD
N. Return of used products
O. Limited Warranty
A. DESCRIPTION
The D903 AVANT VAVD is a microporous hollow fibre membrane oxygenator
consisting of a gas exchange module with an integrated heat exchanger and a
Hardshell Reservoir specifically designed to allow vacuum assisted venous
drainage. The hardshell reservoir is divided into two compartments:
1. Venous Reservoir (fig. 2, ref. 1)
2. Cardiotomy Reservoir with integrated cardiotomy filter (fig. 2, ref. 2)
These two compartments are exclusively connected by means of a connection key
(fig. 2, ref. 3)
The device is single use, non-toxic, non pyrogenic, supplied STERILE and packaged
singly. Sterilised by ethylene oxide.
The level of ethylene oxide residuals in the device is within the limits established by
national regulations in the country of use.
The device is available in the following version:
[A] D903 AVANT VAVD (with 30 μm cardiotomy filter)
B. TECHNICAL FEATURES
- Recommended max blood flow
- Membrane type
- Membrane surface area
- Heat exchanger surface area
- Hardshell Reservoir Capacity
Venous Reservoir
Cardiotomy Reservoir
- Recovered priming volume
(oxygenating module + heat exchanger)
- Connections:
Venous reservoir return
Venous reservoir outlet
Oxygenator venous inlet
Oxygenating module arterial outlet
Vacuum line connector (1/4" adapter supplied)
C. INTENDED USE
The D903 AVANT VAVD is intended for use in cardiopulmonary bypass circuits as a
device to replace the function of the lungs, (transfer of oxygen and removal of
carbon dioxide) to control the arterial/venous temperature and as a venous blood
reservoir.
The blood to be treated should contain anticoagulant.
The D903 AVANT VAVD is an ADULT oxygenator intended for use in procedures on
patients with a body weight of less than 130 Kg (286 lb.). The D903 AVANT VAVD
should not be used longer than 6 hours. Contact with blood for longer periods is not
advised.
The D903 AVANT VAVD should be used in combination with medical devices listed
in section M (Medical devices for use with the D903 AVANT VAVD).
D. SAFETY INFORMATION
Information intended to attract the attention of the user to potentially dangerous
situations and to ensure correct and safe use of the device is indicated in the text in
the following way:
Indicates serious adverse reactions and potential safety hazards for
practitioner and/or patient that can occur in the proper use or misuse of the
device and also the limitations of use and the measures to be adopted in such
cases.
Indicates any special care to be exercised by a practitioner for the safe and
effective use of the device.
EXPLANATION OF THE SYMBOLS USED ON THE LABELS
GB - ENGLISH - INSTRUCTIONS FOR USE
8.0 l/min
Microporous Polypropylene
2.0 m2
0.14 m2
4700 ml
3500 ml
1200 ml
270 ml
1/2" (12.7 mm)
3/8" (9.53 mm)
3/8" (9.53 mm)
3/8" (9.53 mm)
Pos-Lock
The following is general safety information with the aim of advising the operator in
preparing to use the device.
Also, specific safety information is given in the instructions for use at locations in the
text where that information is relevant for correct operation.
- The device must be used in accordance with the instructions for use
provided in this manual.
- The device is intended to be used by professionally trained personnel.
- SORIN GROUP ITALIA is not responsible for problems arising from
inexperience or improper use.
- FRAGILE, handle with care.
- Keep dry. Store at room temperature.
- For single use and for single-patient use only. During use the device is in
contact with human blood, body fluids, liquids or gases for the purpose of
eventual infusion, administration or introduction into the body, and due to
its specific design it cannot be fully cleaned and disinfected after use.
Therefore, reuse on other patients might cause cross-contamination,
infection and sepsis. In addition, the reuse increases the probability of
product failure (integrity, functionality and clinical effectiveness).
- The device contains phthalates. Considering the nature of contact with the
body, the limited duration of contact and the number of treatments per
patient, the amount of phthalates which might be released from the device
does not raise specific concerns about residual risks. Further information is
available on request from Sorin Group Italia
- Always give and maintain a correct dose and accurate monitoring of the
anticoagulant before, during and after the bypass.
- The device must not undergo any further processing.
- Do not resterilise.
GB - ENGLISH
For single use only (Do not reuse)
Batch code (number) (reference for product
traceability)
Use by (Expiry date)
Date of manufacture
Manufactured by
Sterile - Ethylene oxide sterilised
Non Pyrogenic
Contains PHTHALATE
Latex free
Warning: Do not resterilize.
Contents sterile only if package is not opened,
damaged or broken
Catalogue (code) number
Attention, see instruction for use
Attention, see instruction for use
This way up
Fragile; handle with care
Quantity
Keep away from heat
Keep dry
3